As of 2026-04-06, the Relative Valuation of Tandem Diabetes Care Inc (TNDM) is (59.12) USD. This relative valuation is based on P/E multiples. With the latest stock price at 18.61 USD, the upside of Tandem Diabetes Care Inc based on Relative Valuation is -417.7%.
The range of the Relative Valuation is (61.11) - (52.12) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 25.6x - 29.0x | 28.2x |
| Forward P/E multiples | 20.8x - 21.8x | 21.3x |
| Fair Price | (61.11) - (52.12) | (59.12) |
| Upside | -428.4% - -380.1% | -417.7% |
| Date | P/E |
| 2026-04-02 | -7.78 |
| 2026-04-01 | -7.87 |
| 2026-03-31 | -8.02 |
| 2026-03-30 | -8.19 |
| 2026-03-27 | -8.78 |
| 2026-03-26 | -9.75 |
| 2026-03-25 | -10.15 |
| 2026-03-24 | -10.25 |
| 2026-03-23 | -10.49 |
| 2026-03-20 | -10.38 |
| 2026-03-19 | -10.30 |
| 2026-03-18 | -9.98 |
| 2026-03-17 | -10.00 |
| 2026-03-16 | -9.16 |
| 2026-03-13 | -9.03 |
| 2026-03-12 | -8.73 |
| 2026-03-11 | -9.27 |
| 2026-03-10 | -9.15 |
| 2026-03-09 | -8.73 |
| 2026-03-06 | -8.84 |
| 2026-03-05 | -9.46 |
| 2026-03-04 | -9.79 |
| 2026-03-03 | -9.93 |
| 2026-03-02 | -10.55 |
| 2026-02-27 | -10.58 |
| 2026-02-26 | -10.79 |
| 2026-02-25 | -10.88 |
| 2026-02-24 | -11.25 |
| 2026-02-23 | -11.82 |
| 2026-02-20 | -10.28 |
| 2026-02-19 | -7.75 |
| 2026-02-18 | -7.92 |
| 2026-02-17 | -7.88 |
| 2026-02-13 | -7.93 |
| 2026-02-12 | -7.82 |
| 2026-02-11 | -8.22 |
| 2026-02-10 | -8.17 |
| 2026-02-09 | -7.90 |
| 2026-02-06 | -8.02 |
| 2026-02-05 | -7.92 |
| 2026-02-04 | -7.94 |
| 2026-02-03 | -8.13 |
| 2026-02-02 | -8.40 |
| 2026-01-30 | -8.32 |
| 2026-01-29 | -8.26 |
| 2026-01-28 | -7.99 |
| 2026-01-27 | -8.43 |
| 2026-01-26 | -8.45 |
| 2026-01-23 | -8.32 |
| 2026-01-22 | -8.61 |